[Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colonic cancer cell line HT-29]

Ai Zheng. 2008 Nov;27(11):1172-6.
[Article in Chinese]

Abstract

Background & objective: Studies have shown that estrogen receptor beta (ERbeta), which is highly expressed in colorectal cancer, is related to tumor metastasis. Matrix metalloproteinase (MMP)-7 is overexpressed in colorectal cancer, and plays an important role in tumor invasion and metastasis. This study was to explore the effect of tamoxifen (TAM) on apoptosis and MMP-7 expression in ERbeta-positive human colorectal cancer cell line HT-29.

Methods: After exposure to TAM, the proliferation of HT-29 cells was detected by MTT assay; cell apoptosis was evaluated using flow cytometry; expressions of ERbeta and MMP-7 were measured by Western blot.

Results: TAM significantly inhibited cell growth of HT-29 in a time (24 h, 48 h, 72 h )-and dose (0, 10(-7), 10(-6), 10(-5),0 10(-4) mol/L )-dependent manner. TAM exposure caused significant cell apoptosis of HT-29 cells at the concentration of 10(-4) mol/L [(69.9+/-4.2)%]. Moreover, TAM could bind to ERbeta to down-regulate MMP-7 protein expression in HT-29 cells.

Conclusion: High concentration of TAM can inhibit the proliferation of ERbeta-positive HT-29 cells, and effectively bind with ERbeta to down-regulate MMP-7 expression.

Publication types

  • English Abstract

MeSH terms

  • Antineoplastic Agents, Hormonal / pharmacology*
  • Apoptosis / drug effects*
  • Cell Proliferation
  • Estrogen Receptor beta / metabolism*
  • HT29 Cells
  • Humans
  • Matrix Metalloproteinase 7 / metabolism*
  • Tamoxifen / pharmacology*

Substances

  • Antineoplastic Agents, Hormonal
  • Estrogen Receptor beta
  • Tamoxifen
  • MMP7 protein, human
  • Matrix Metalloproteinase 7